Background: Liver iron and fat are often co-deposited, synergistically aggravating the progression of chronic liver disease. Accurate determination of liver iron and fat content is helpful for patient management. To assess the accuracy of hepatic iron/fat decomposition using dual-energy computed tomography (DECT) for simultaneously quantifying hepatic iron and fat when both are present. Methods: Sixty-eight New Zealand rabbits on a high-fat/cholesterol diet plus iron injections were used to establish a model of coexisting hepatic iron/fat. Abdominal imaging was performed using dual-source DECT. The iron and fat fractions (Iron-CT and Fat-CT, respectively) were calculated using a 3-material decomposition algorithm. The spectroscopic liver iron concentration (LIC) grading (normal, mild, moderate, severe, and massive iron overload) and the histopathological fat fraction (Fat-ref) grading (normal, mild, moderate, severe steatosis) were used as references. Correlations between the DECT parameters and the references were analyzed. Hepatic iron/fat quantification equations were established and validated. Analysis of covariance was used to assess the influence of fat on iron measurements and vice versa. Results: Iron-CT highly correlated with LIC (r=0.94, P<0.001), and Fat-CT highly correlated with Fat-ref (r=0.88, P15.0 mg Fe/g (270 µmol/g)] the regression began to deviate, causing fat underestimation (F=5.50, P=0.04). Conclusions: Our DECT-based iron/fat decomposition algorithm accurately measured hepatic iron and fat when both were present in a rabbit model. Hepatic fat may be underestimated when there is massive iron overload.
To investigate the feasibility of radiomics models for predicting the source of hepatic metastases from gastrointestinal (GI) vs. non-gastrointestinal (non-GI) primary tumors on contrast enhanced CT(CECT). 347 patients with liver metastases (180 from GI and 167 from non-GI) and abdominal CECT including arterial, portal venous, and delayed phases were divided into training (221) and validation (96) sets at a ratio of 7:3 and an independent testing set (30). Radiomics features were extracted from volumes of interest (VOIs) including tumoral (Vtc) and peritumoral (Vpt) regions on CECT. Optimal radiomics features were used in logistic regression models using receiver operating curve (ROC) analysis to evaluate the diagnostic efficiency. The best single-phase model was a venous phase peritumoral VOI with 11 features. Area under the curve (AUC), sensitivity and specificity were 0.817, 0.740 and 0.761, respectively in the validation set. While the best arterial phase tumoral VOI gave an AUC of 0.677 in the validation set. For the combined models, peritumoral VOI in arterial and venous phases (15 features) achieved the best prediction performance with an AUC of 0.926 in the validation set and 0.884 in the testing set. Liver peritumoral radiomics features extracted from CECT were able to identify the source of hepatic metastases as GI versus non-GI. Peritumoral radiomics features showed a correlation with source of liver metastases. The radiomics features from liver peritumoral arterial and venous phases CT were promising in differentiating the source of hepatic metastases from GI vs. non-GI primary tumors.